MedTrace Logo

EucaLimus Post-Market Registry

NCT06621524 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 251

Last updated 2026-03-11

No results posted yet for this study

Summary

To collect post marketing surveillance data on consecutive patients with coronary heart disease intended to be or treated by the Eucalimus sirolimus eluting PTCA stent when used according to the Instructions for Use. Data will be collected in order to assess the long term safety and performance of the Eucalimus PTCA stent in routine clinical practice.

Conditions

  • Coronary Arterioscleroses

Interventions

DEVICE

EucaLimus coronary stent system

The EucaLimus coronary stent system is a drug-coated coronary stent system, indicated for use in patients with symptomatic ischaemic coronary heart disease due to de novo lesions or restenosed lesions of the coronary arteries.

Sponsors & Collaborators

  • Eucatech AG

    collaborator INDUSTRY

  • Centre Européen de Recherche Cardiovasculaire

    collaborator UNKNOWN

  • OrbusNeich

    lead INDUSTRY

Principal Investigators

  • Josep Gomez-Lara, MD, PhD · Bellvitge University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-14
Primary Completion
2027-01-31
Completion
2029-01-31

Countries

  • Czechia
  • Malaysia
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06621524 on ClinicalTrials.gov